Infinity Stock Valuation

INFI -  USA Stock  

USD 2.59  0.06  2.26%

Do you want to know what the current value of Infinity Pharmaceuti is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Infinity Pharmaceuti, is its stock price multiplied by the total number of shares outstanding, calculating Infinity Pharmaceuti's enterprise value requires a different approach. It uses Infinity Pharmaceuti's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Infinity Pharmaceuti Enterprise Value is most likely to decrease significantly in the upcoming years. The preceding year's Enterprise Value was reported at 119.15 Million. The current Tangible Asset Value is estimated to increase to about 40.4 M, while Free Cash Flow is projected to decrease to (38.6 M).
Infinity Pharmaceuti retains a regular Real Value of $4.08 per share. The prevalent price of the firm is $2.59. Based on Macroaxis valuation methodology, the firm appears to be undervalued. Our model calculates the value of Infinity Pharmaceuti from evaluating the firm fundamentals such as Shares Owned by Insiders of 2.17 %, return on equity of (285.39) %, and Return On Asset of (34.64) % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Infinity Valuation 

Infinity Pharmaceuti Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Infinity Pharmaceuti's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
23rd of October 2021
Please note that Infinity Pharmaceuti's price fluctuation is dangerous at this time. Calculation of the real value of Infinity Pharmaceuti is based on 3 months time horizon. Increasing Infinity Pharmaceuti's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Infinity Pharmaceuti is useful when determining the fair value of the Infinity stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Infinity Pharmaceuti. Since Infinity Pharmaceuti is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Infinity Stock. However, Infinity Pharmaceuti's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Infinity Pharmaceuti helps investors to forecast how Infinity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Infinity Pharmaceuti more accurately as focusing exclusively on Infinity Pharmaceuti's fundamentals will not take into account other important factors:
Estimates (5)
LowProjected EPSHigh
LowEstimated ValueHigh
LowNext ValueHigh
6 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Infinity Pharmaceuti's intrinsic value based on its ongoing forecasts of Infinity Pharmaceuti's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Infinity Pharmaceuti's closest peers. When choosing an evaluation method for Infinity Pharmaceuti, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Infinity Pharmaceuti Investments

5.83 MillionShare

Infinity Valuation Drivers Correlation

Many accounts on the financial statements of Infinity Pharmaceuti are highly interrelated and sometimes correlated. Consequently, when conducting Infinity's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Infinity
Click cells to compare fundamentals

Infinity Valuation Trend

Knowing Infinity Pharmaceuti's actual value is paramount for traders to make sound investment determinations. Infinity Pharmaceuti's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Infinity Pharmaceuti's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Infinity Pharmaceuti's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Infinity Market Cap

Infinity Pharmaceuti is rated second overall in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 1.54 Billion. Infinity Pharmaceuti retains roughly 234.03 Million in market capitalization claiming about 15% of stocks in Biotechnology industry.
Capitalization  Workforce  Total debt  Valuation  Revenue

Infinity Pharmaceuti Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Infinity Pharmaceuti's current stock value. Our valuation model uses many indicators to compare Infinity Pharmaceuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infinity Pharmaceuti competition to find correlations between indicators driving Infinity Pharmaceuti's intrinsic value. More Info.
Infinity Pharmaceuti is currently regarded as number one stock in price to book category among related companies. It is rated second overall in price to earning category among related companies . . The current Price to Earnings Ratio is estimated to decrease to -3.36. The current Earnings Before Interest Taxes and Depreciation Amortization EBITDA is estimated to decrease to about (40.5 M)

About Infinity Pharmaceuti Valuation

The equity valuation mechanism determines the current worth of Infinity Pharmaceuti on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Infinity Pharmaceuti. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Infinity Pharmaceuti based exclusively on its fundamental and basic technical indicators. By analyzing Infinity Pharmaceuti's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Infinity Pharmaceuti's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Infinity Pharmaceuti. We calculate exposure to Infinity Pharmaceuti's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Infinity Pharmaceuti's related companies.
Last ReportedProjected for 2021
Gross Profit1.7 M1.8 M
Profit Margin(23.56) (24.18) 
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.

Infinity Pharmaceuti Quarterly Enterprise Value

159.61 MillionShare

Infinity Pharmaceuti Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Infinity Pharmaceuti does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio9.22
Revenue Growth42.20%
Enterprise Value To Ebitda-4.87
Enterprise Value To Revenue105.57

Infinity Pharmaceuti Current Valuation Indicators

Valuation refers to the process of determining the present value of Infinity Pharmaceuti and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Infinity we look at many different elements of the entity such as Infinity's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
CEO Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.